These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31963118)

  • 41. An RNA polymerase II-driven Ebola virus minigenome system as an advanced tool for antiviral drug screening.
    Nelson EV; Pacheco JR; Hume AJ; Cressey TN; Deflubé LR; Ruedas JB; Connor JH; Ebihara H; Mühlberger E
    Antiviral Res; 2017 Oct; 146():21-27. PubMed ID: 28807685
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ebola Virus Persistence in Semen of Male Survivors.
    Uyeki TM; Erickson BR; Brown S; McElroy AK; Cannon D; Gibbons A; Sealy T; Kainulainen MH; Schuh AJ; Kraft CS; Mehta AK; Lyon GM; Varkey JB; Ribner BS; Ellison RT; Carmody E; Nau GJ; Spiropoulou C; Nichol ST; Ströher U
    Clin Infect Dis; 2016 Jun; 62(12):1552-1555. PubMed ID: 27045122
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genome-Wide Search for Competing Endogenous RNAs Responsible for the Effects Induced by Ebola Virus Replication and Transcription Using a trVLP System.
    Wang ZY; Guo ZD; Li JM; Zhao ZZ; Fu YY; Zhang CM; Zhang Y; Liu LN; Qian J; Liu LN
    Front Cell Infect Microbiol; 2017; 7():479. PubMed ID: 29209594
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modeling Ebola Virus Genome Replication and Transcription with Minigenome Systems.
    Cressey T; Brauburger K; Mühlberger E
    Methods Mol Biol; 2017; 1628():79-92. PubMed ID: 28573612
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel Small Molecule Entry Inhibitors of Ebola Virus.
    Basu A; Mills DM; Mitchell D; Ndungo E; Williams JD; Herbert AS; Dye JM; Moir DT; Chandran K; Patterson JL; Rong L; Bowlin TL
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S425-34. PubMed ID: 26206510
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Insights into Ebola Virus VP35 and VP24 Interferon Inhibitory Functions and their Initial Exploitation as Drug Targets.
    Fanunza E; Frau A; Corona A; Tramontano E
    Infect Disord Drug Targets; 2019; 19(4):362-374. PubMed ID: 30468131
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists.
    Cheng H; Lear-Rooney CM; Johansen L; Varhegyi E; Chen ZW; Olinger GG; Rong L
    J Virol; 2015 Oct; 89(19):9932-8. PubMed ID: 26202243
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A GXXXA Motif in the Transmembrane Domain of the Ebola Virus Glycoprotein Is Required for Tetherin Antagonism.
    González-Hernández M; Hoffmann M; Brinkmann C; Nehls J; Winkler M; Schindler M; Pöhlmann S
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29669839
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model.
    Oestereich L; Lüdtke A; Wurr S; Rieger T; Muñoz-Fontela C; Günther S
    Antiviral Res; 2014 May; 105():17-21. PubMed ID: 24583123
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical Laboratory Values as Early Indicators of Ebola Virus Infection in Nonhuman Primates.
    Reisler RB; Yu C; Donofrio MJ; Warren TK; Wells JB; Stuthman KS; Garza NL; Vantongeren SA; Donnelly GC; Kane CD; Kortepeter MG; Bavari S; Cardile AP
    Emerg Infect Dis; 2017 Aug; 23(8):1316-1324. PubMed ID: 28726603
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Electron Microscopy of Ebola Virus-Infected Cells.
    Noda T
    Methods Mol Biol; 2017; 1628():243-250. PubMed ID: 28573625
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibiting pyrimidine biosynthesis impairs Ebola virus replication through depletion of nucleoside pools and activation of innate immune responses.
    Luthra P; Naidoo J; Pietzsch CA; De S; Khadka S; Anantpadma M; Williams CG; Edwards MR; Davey RA; Bukreyev A; Ready JM; Basler CF
    Antiviral Res; 2018 Oct; 158():288-302. PubMed ID: 30144461
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.
    Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907
    [No Abstract]   [Full Text] [Related]  

  • 54. Evaluation of Ebola Virus Countermeasures in Guinea Pigs.
    Marzi A
    Methods Mol Biol; 2017; 1628():283-291. PubMed ID: 28573629
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oral and Conjunctival Exposure of Nonhuman Primates to Low Doses of Ebola Makona Virus.
    Mire CE; Geisbert JB; Agans KN; Deer DJ; Fenton KA; Geisbert TW
    J Infect Dis; 2016 Oct; 214(suppl 3):S263-S267. PubMed ID: 27284090
    [TBL] [Abstract][Full Text] [Related]  

  • 56. VP24 is a molecular determinant of Ebola virus virulence in guinea pigs.
    Mateo M; Carbonnelle C; Reynard O; Kolesnikova L; Nemirov K; Page A; Volchkova VA; Volchkov VE
    J Infect Dis; 2011 Nov; 204 Suppl 3():S1011-20. PubMed ID: 21987737
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ebola virus infection modeling and identifiability problems.
    Nguyen VK; Binder SC; Boianelli A; Meyer-Hermann M; Hernandez-Vargas EA
    Front Microbiol; 2015; 6():257. PubMed ID: 25914675
    [TBL] [Abstract][Full Text] [Related]  

  • 58. IL-4/IL-13 polarization of macrophages enhances Ebola virus glycoprotein-dependent infection.
    Rogers KJ; Brunton B; Mallinger L; Bohan D; Sevcik KM; Chen J; Ruggio N; Maury W
    PLoS Negl Trop Dis; 2019 Dec; 13(12):e0007819. PubMed ID: 31825972
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A conserved transcriptional response to intranasal Ebola virus exposure in nonhuman primates prior to onset of fever.
    Speranza E; Bixler SL; Altamura LA; Arnold CE; Pratt WD; Taylor-Howell C; Burrows C; Aguilar W; Rossi F; Shamblin JD; Wollen SE; Zelko JM; Minogue T; Nagle E; Palacios G; Goff AJ; Connor JH
    Sci Transl Med; 2018 Mar; 10(434):. PubMed ID: 29593102
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The cytoprotective enzyme heme oxygenase-1 suppresses Ebola virus replication.
    Hill-Batorski L; Halfmann P; Neumann G; Kawaoka Y
    J Virol; 2013 Dec; 87(24):13795-802. PubMed ID: 24109237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.